A report by researchers at Trilliant Health found that common symptoms—such as cough, nausea and rash—are often coded as complex medical events, resulting in higher reimbursement rates.
Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.
Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs.
Tom Price, MD, an orthopedic surgeon, and former secretary of Health and Human Services (HHS) is an advocate for changing immigration policy to help solve the growing shortage of doctors and nurses in the U.S.
Scott Whitaker, the CEO of the industry lobby AvaMed, told the Senate Finance Committee that he fears tariffs will only raise the cost of care and put patients at risk if companies are unable to overcome supply chain disruptions.
Specialists with Duke University Medical System will participate in a free webinar focused on their experience treating heart failure with the implantable Barostim technology from CVRx.
New data out of Sweden show that using Abbott's continuous glucose monitor technology is associated with a reduced risk of being hospitalized for cardiac complications. This was true for patients with and without a history of prior heart disease.
A Biden-era update to the law would require private insurers to update their networks to ensure patients have access to mental and behavioral health services, with those services reimbursed in a manner similar to physical care.
Leadership is not easy, but it is worth doing. According to one seasoned healthcare executive, the world needs more physicians to move into leadership positions.
Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.
Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs.
